[1]
“Comparative Assessment Of Health-Related Quality Of Life In Osteoporosis Patients Treated With Teriparatide Versus Zoledronic Acid: A Prospective, Observational Study Using The OPAQ-SV Questionnaire”, Int. J. Environ. Sci., pp. 1063–1068, Jul. 2025, doi: 10.64252/zgx5f476.